The leukemogenic activity of taxHTLV-1 during human alphabeta T cell development

Frontiers in Bioscience - Scholar

Volumn 1 S, Issue 1, 2009, Pages 194-204

  Wencker, Melanie ^a,b   Gazzolo, Louis ^a,b   Dodon, Madeleine Duc ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b University Lyon i   (France)

Author keywords

ATL; HTLV 1; Human thymocytes; Leukemogenesis; Review; T cell development; Tax

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; TAX PROTEIN; TAX PROTEIN, HUMAN T LYMPHOTROPHIC VIRUS 1; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1;

CELL TRANSFORMATION; CYTOLOGY; HUMAN; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

CELL TRANSFORMATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMANS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 77954478751     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/e19     Document Type: Article

References (63)

1. Vogelstein, B., and K. W. Kinzler, Cancer genes and the pathways they control. Nat. Med. 10, 789-789 (2004)
2. Takatsuki, K., Discovery of adult T-cell leukemia. Retrovirology 2, 16 (2005)
3. Franchini G., R. Fukumoto, and J. R. Fullen, T-cell control by human T-cell leukemia/lymphoma virus type 1. Int. J. Hematol. 78, 280-280 (2003)
4. Matsuoka M., and K. T. Jeang. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7, 270-270 (2007)
5. Basbous, J., C. Arpin, G. Gaudray, M. Piechaczyk, C. Devaux, and J. M. Mesnard. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun. and modulates their transcriptional activity. J. Biol. Chem. 278, 4362043627 (2003)
6. Gaudray, G, F. Gachon, J. Basbous, M. Biard-Piechaczyk, C. Devaux, and J. M. Mesnard. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription J. Virol. 76, 12813-22 (2002) (Pubitemid 35386965)
7. Mesnard, J. M., B. Barbeau, and C. Devaux. HBZ, a new important player in the mystery of adult T-cell leukemia. Blood 108, 3979-3979 (2006)
8. Foulds L., Tumor progression. Cancer Res. 17, 355-355 (1957)
9. Nowell, P. C. Tumor progression: a brie. historical perspective. Semin. Cancer Biol. 12, 261-261 (2002)
10. Gery S., and H. P. Koeffler, Transcription factors in hematopoietic malignancies. Curr. Opin. Genet. Dev. 17, 78-78 (2007)
11. M. A. Blasco, and W. C. Hahn, Evolving views of telomerase and cancer. Trends Cell Biol. 13, 289-289 (2003)
12. Warner J. K., J. C. Wang, K. J. Hope, L. Jin, and J. E. Dick, Concepts of human leukemic development. Oncogene 23, 7164-7164 (2004)
13. Bangham C. R., The immune response to HTLV-I. Curr. Opin. Immunol. 12, 397-397 (2000)
14. Hanon E., S. Hall, G. P. Taylor, M. Saito, R. Davis, Y. Tanaka, K. Usuku, M. Osame, J. N. Weber, and C. R. Bangham, Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95, 1386-1386 (2000)
15. Shimoyama M., Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79, 428-428 (1991)
16. Miyazaki M., J. Yasunaga, Y. Taniguchi, S. Tamiya, T. Nakahata, and M. Matsuoka, Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis. J. Virol. 81, 5714-5714 (2007)
17. Kubuki Y., M. Suzuki, H. Sasaki, T. Toyama, K. Yamashita, K. Maeda, A. Ido, H. Matsuoka, A. Okayama, T. Nakanishi, and H. Tsubouchi, Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia. Leuk. Lymphoma 46, 393-393 (2005)
18. Nakano S., Y. Ando, K. Saito, I. Moriyama, M. Ichijo, T. Toyama, K. Sugamura, J. Imai, and Y. Hinuma, Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidenc. for viral transmission from mothers to children. J. Infect. 12, 205-205 (1986)
19. Hasegawa A., T. Ohashi, S. Hanabuchi, H. Kato, F. Takemura, T. Masuda, and M. Kannagi, Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: invers. correlation with HTLV-1-specific cellular immune response. J. Virol. 77, 2956-2956 (2003)
20. Kannagi M., T. Ohashi, N. Harashima, S. Hanabuchi, and A. Hasegawa, Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Trends Microbiol. 12, 346-346 (2004)
21. Yssel H., R. de Waal Malefyt, M. Duc Dodon, D. Blanchard, L. Gazzolo, J. E. de Vries, and H. Spits, Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. J. Immunol. 142, 2279-2279 (1989)
22. Kimata J. T., and L. Ratner, Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65, 4398-4398 (1991)
23. Jeang K. T., C. Z. Giam, F. Majone, and M. Aboud, Life, death, and Tax: rol. of HTLV-I oncoprotein in genetic instability and cellular transformation. J. Biol. Chem. 279, 31991-31991 (2004)
24. Iwanaga Y., T. Tsukahara, T. Ohashi, Y. Tanaka, M. Arai, M. Nakamura, K. Ohtani, Y. Koya, M. Kannagi, N. Yamamoto, and M. Fujii, Human T-cell leukemia virus type 1 Tax protein abrogates interleukin-2 dependence in a mouse T-cell line. J. Virol. 73, 1271-1271 (1999)
25. Ohtani K., R. Iwanaga, M. Arai, Y. Huang, Y. Matsumura, and M. Nakamura, Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. J. Biol. Chem. 275, 11154-11154 (2000)
26. Akagi T., H. Ono, and K. Shimotohno, Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood 86, 4243-4243 (1995)
27. Akagi T., H. Ono, and K. Shimotohno, Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possibl. involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene 12, 1645-1645 (1996)
28. Akagi T., and K. Shimotohno, Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J. Virol. 67, 1211-1211 (1993)
29. Grassmann R., C. Dengler, I. Muller-Fleckenstein, B. Fleckenstein, K. McGuire, M. C. Dokhelar, J. G. Sodroski, and W. A. Haseltine, Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc. Natl. Acad. Sci. U S A 86, 3351-3351 (1989)
30. Schmitt I., O. Rosin, P. Rohwer, M. Gossen, and R. Grassmann, Stimulation of cyclin-dependent kinase activity and G1-to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J. Virol. 72, 633-633 (1998)
31. Spits H., Development of alphabeta T cells in the human thymus. Nat. Rev. Immunol. 2, 760-760 (2002)
32. Anderson M. K., At the crossroads: divers. roles of early thymocyte transcriptional regulators. Immunol. Rev. 209, 191-191 (2006)
33. Aifantis I., M. Mandal, K. Sawai, A. Ferrando, and T. Vilimas, Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. Immunol. Rev. 209, 159-159 (2006)
34. Reizis B., and P. Leder, Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev. 16, 295-295 (2002)
35. Xie H., Z. Huang, M. S. Sadim, and Z. Sun, Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL. J. Immunol. 175, 7981-7981 (2005)
36. Hsu L. Y., L, J. Lauring, H. E. Liang, S. Greenbaum, D. Cado, Y. Zhuang, and M. S. Schlissel, A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105-105 (2003)
37. Kim D., M. Xu, L. Nie, X. C. Peng, E. Jimi, R. E. Voll, T. Nguyen, S. Ghosh, and X. H. Sun, Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities. Immunity 16, 9-9 (2002)
38. Takeuchi A., S. Yamasaki, K. Takase, F. Nakatsu, H. Arase, M. Onodera and T. Saito, E2A and HEB activate the pre-TCR alpha promoter during immature T cell development. J. Immunol. 167, 2157-2157 (2001)
39. Blom B., M. H. Heemskerk, M. C. Verschuren, J. J. van Dongen, A. P. Stegmann, A. Q. Bakker, F. Couwenberg, P. C. Res, and H. Spits, Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loophelix protein Id3 in committed T cell progenitors. Embo J. 18, 2793-2793 (1999)
40. Bellavia D., A. F. Campese, E. Alesse, A. Vacca, M. P. Felli, A. Balestri, A. Stoppacciaro, C. Tiveron, L. Tatangelo, M. Giovarelli, C. Gaetano, L. Ruco, E. S. Hoffman, A. C. Hayday, U. Lendahl, L. Frati, A. Gulino, and I. Screpanti, Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. Embo J. 19, 3337-3337 (2000)
41. O'Neil J., J. Shank, N. Cusson, C. Murre, and M. Kelliher, TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 5, 587-587 (2004)
42. Talora C. S., S. Cialfi, C. Oliviero, R. Palermo, M. Pascucci, L. Frati, A. Vacca, A. Gulino, and I. Screpanti, Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis. Blood 107, 3313-3313 (2006)
43. Guo Z., M. Dose, D. Kovalovsky, R. Chang, J. O'Neil, A. T. Look, H. von Boehmer, K. Khazaie, and F. Gounari, Beta-catenin stabilization stalls the transition from doublepositive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 109, 5463-5463 (2007)
44. Bain G., I. Engel, E. C. Robanus Maandag, H. P. te Riele, J. R. Voland, L. L. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre, E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782-4782 (1997)
45. Engel I., C. Johns, G. Bain, R. R. Rivera, and C. Murre, Early thymocyte development is regulated by modulation of E2A protein activity. J. Exp. Med. 194, 733-733 (2001)
46. Kim D., X. C. Peng, and X. H. Sun, Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol. Cell. Biol. 19, 8240-8240 (1999)
47. Ciminale V., M. Hatziyanni, B. K. Felber, J. Bear, A. Hatzakis, and G. N. Pavlakis, Unusual CD4+CD8+ phenotype in a greek patient diagnosed with adult T-cell leukemia positive for human T-cell leukemia virus type I (HTLV-I). Leuk Res, 24, 353-353 (2000)
48. Kamihira S., H. Sohda, S. Atogami, T. Fukushima, K. Toriya, Y. Miyazaki, S. Ikeda, Y. Yamada, and M. Tomonaga, Unusual morphological features of adult T-cell leukemia cells with aberrant immunophenotype. Leuk. Lymphoma 12, 123-123 (1993)
49. Suzushima H., N. Asou, S. Nishimura, K. Nishikawa, J. X. Wang, T. Okubo, M. Naito, T. Hattori, and K. Takatsuki, Double-negative (CD4-CD8-) T cells from adult T-cell leukemia patients also have poor expression of the T-cell receptor alpha beta/CD3 complex. Blood 81, 1032-1032 (1993)
50. Feuer G., J. K. Fraser, J. A. Zack, F. Lee, R. Feuer, and I. S. Chen, Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenanc. of virus infection during differentiation in vitro and in vivo. J. Virol. 70, 4038-4038 (1996)
51. Maguer-Satta V., L. Gazzolo, and M. Duc Dodon, Human immature thymocytes as target cells of the leukemogenic activity of human T-cell leukemia virus type I. Blood 86, 1444-1444 (1995)
52. Simpson R. M., T. M. Zhao, B. S. Hubbard, S. Sawasdikosol, and T. J. Kindt, Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection. Lab. Invest. 74, 696-696 (1996)
53. Nerenberg M., S. H. Hinrichs, R. K. Reynolds, G. Khoury and G. Jay, The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237, 1324-1324 (1987)
54. Kuo Y. L., and C. Z. Giam, Activation of the anaphase promoting complex by HTLV-1 Tax leads to senescence. Embo J. 25, 1741-1741 (2006)
55. Tripp A., P. Banerjee, M. Sieburg, V. Planelles, F. Li, and G. Feuer, Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulatio. of p21cip1/waf1 and p27kip1 expression. J. Virol. 79, 14069-14069 (2005)
56. Hasegawa H., H. Sawa, M. J. Lewis, Y. Orba, N. Sheehy, Y. Yamamoto, T. Ichinohe, Y. Tsunetsugu-Yokota, H. Katano, H. Takahashi, J. Matsuda, T. Sata, T. Kurata, K. Nagashima, and W. W. Hall, Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 12, 466-466 (2006)
57. Wencker M., C. Sausse, D. Derse, L. Gazzolo, and M. Duc Dodon, Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes. J. Virol. 81, 301-301 (2007)
58. Manel N., F. J. Kim, S. Kinet, N. Taylor, M. Sitbon, and J. L. Battini, The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449-449 (2003)
59. Swainson L., S. Kinet, N. Manel, J. L. Battini, M. Sitbon, and N. Taylor, Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis. Proc. Natl. Acad. Sci. U S A 102, 12867-12867 (2005)
60. Mandal M., C. Borowski, T. Palomero, A. A. Ferrando, P. Oberdoerffer, F. Meng, A. Ruiz-Vela, M. Ciofani, J. C. Zuniga-Pflucker, I. Screpanti, A. T. Look, S. J. Korsmeyer, K. Rajewsky, H. von Boehmer, and I. Aifantis, The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J. Exp. Med. 201, 603-603 (2005)
61. Tomita M., A. Kikuchi, T. Akiyama, Y. Tanaka, and N. Mori, Human T-cell leukemia virus type 1 Tax dysregulates beta-catenin signaling. J. Virol. 80, 10497-10497 (2006)
62. Manz M. G., Human-hemato-lymphoid-system mice: opportunitie. and challenges. Immunity 26, 537-537 (2007)
63. Schmitt T. M., and J. C. Zuniga-Pflucker, T-cell development, doing it in a dish. Immunol. Rev. 209, 95-95 (2006)